Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2022 Mar-Apr;36(2):556-562.
doi: 10.21873/invivo.12737.

Soy Isoflavones and Breast Cancer Risk: A Meta-analysis

Affiliations
Meta-Analysis

Soy Isoflavones and Breast Cancer Risk: A Meta-analysis

Ioannis Boutas et al. In Vivo. 2022 Mar-Apr.

Abstract

Background/aim: Soy contains genistein and daidzein isoflavones. Isoflavones are phytoestrogens, with a similarity in structure to human 17-β estradiol hormone. They imitate the action of estrogen on organs by binding and activating estrogen receptors. Numerous studies have examined the relationship between soy consumption and breast cancer but not the amount of consumption itself. We performed a systematic review of the literature in order to determine whether the amount of soy and isoflavones consumed has a positive effect in pre- and post-menopausal women.

Materials and methods: Data gathering was performed following PRISMA guidelines. Narrowing down the result set for all relevant data was performed via title, abstract, full-text evaluation and the snowball procedure. The selected articles had all relevant data extracted. Analysis of the data was performed using Cochrane's Review Manager statistical analysis tool in order to draw conclusions regarding the positive effect for the amount of soy and isoflavones consumed.

Results: Significant results were found when statistically analyzing data from prospective studies which compared soy isoflavones consumption, breast cancer risk and occurrence. The data were indicative of a clear inverse correlation between the amount of isoflavones consumed and breast cancer occurrence in pre- and post-menopausal women.

Conclusion: The consumption of soy isoflavones can reduce the risk of breast cancer in pre-menopausal and post-menopausal women.

Keywords: Soy; breast cancer risk; isoflavones; meta-analysis; review.

PubMed Disclaimer

Conflict of interest statement

The Authors declare no conflicts of interest.

Figures

Figure 1
Figure 1. PRISMA flow diagram for study selection.
Figure 2
Figure 2. Forest plot of the prevalence of breast cancer in women in selected studies based on the amount of isoflavones they consumed. CI: Confidence interval.
Figure 3
Figure 3. Forest plot on the prevalence of breast cancer in the total study populations based on the amount of isoflavones they consumed. CI: Confidence interval.
Figure 4
Figure 4. Breast cancer cases based on soy isoflavone consumption for pre-menopausal women in selected studies. CI: Confidence interval.
Figure 5
Figure 5. Breast cancer cases based on soy isoflavone consumption for post-menopausal women in selected studies. CI: Confidence interval.

References

    1. National Cancer Institute 2021: Breast Cancer – Patient Version. Available at https://www.cancer.gov/types/breast. [Last accessed on November 12th, 2021]
    1. Bandera EV, King M, Chandran U, Paddock LE, Rodriguez-Rodriguez L, Olson SH. Phytoestrogen consumption from foods and supplements and epithelial ovarian cancer risk: a population-based case control study. BMC Womens Health. 2011;11:40. doi: 10.1186/1472-6874-11-40. - DOI - PMC - PubMed
    1. Barnes S, Prasain J, D’Alessandro T, Arabshahi A, Botting N, Lila MA, Jackson G, Janle EM, Weaver CM. The metabolism and analysis of isoflavones and other dietary polyphenols in foods and biological systems. Food Funct. 2011;2(5):235–244. doi: 10.1039/c1fo10025d. - DOI - PMC - PubMed
    1. Yang S, Zhou Q, Yang X. Caspase-3 status is a determinant of the differential responses to genistein between MDA-MB-231 and MCF-7 breast cancer cells. Biochim Biophys Acta. 2007;1773(6):903–911. doi: 10.1016/j.bbamcr.2007.03.021. - DOI - PubMed
    1. Hatono M, Ikeda H, Suzuki Y, Kajiwara Y, Kawada K, Tsukioki T, Kochi M, Suzawa K, Iwamoto T, Yamamoto H, Shien T, Yamane M, Taira N, Doihara H, Toyooka S. Effect of isoflavones on breast cancer cell development and their impact on breast cancer treatments. Breast Cancer Res Treat. 2021;185(2):307–316. doi: 10.1007/s10549-020-05957-z. - DOI - PubMed